Diosmin Alleviates Doxorubicin-Induced Liver Injury via Modulation of Oxidative Stress-Mediated Hepatic Inflammation and Apoptosis via NfkB and MAPK Pathway: A Preclinical Study

• Κύριοι συγγραφείς: Abdullah F. AlAsmari (Συγγραφέας), Metab Alharbi (Συγγραφέας), Faleh Alqahtani (Συγγραφέας), Fawaz Alasmari (Συγγραφέας), Mohammed AlSwayyed (Συγγραφέας), Sami I. Alzarea (Συγγραφέας), Ibrahim A. Al-Alallah (Συγγραφέας), Adel Alghamdi (Συγγραφέας), Hassan M. Hakami (Συγγραφέας), Meshal K. Alyousef (Συγγραφέας), Youssef Sari (Συγγραφέας), Nemat Ali (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: MDPI AG, 2021-12-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Hepatotoxicity caused by chemotherapeutic drugs (e.g., doxorubicin) is of critical concern in cancer therapy. This study focused on investigating the modulatory effects of diosmin against doxorubicin-induced hepatotoxicity in Male Wistar rats. Male Wistar rats were randomly divided into four groups:...